was risen by 2.50%. And the sales value of Specialty Chemicals business unit was decreased by 7.97%. The 1.80% decrease in total sales revenue was mainly due to the decline in sales value of Commodity

included other income) increased substantially by 16% yoy. EBITDA margin rose from 25% of hospital revenue in 4Q18 to 26% in 4Q19. This was mainly attributable to the increase of non-SW revenue. Financing

same quarter of the previous year (increased by 3.6 percent from Q3/2019), mainly due to the increased proportion of new season seaweed which accounted for decreasing costs, and the growing utilization

revenues of Baht 2,190.9 million and increased by Baht 1,577.2 million or 257.0% compared to the total revenues of Baht 613.7 million for 2018. The increase was mainly due to higher revenue from palm oil

the capital market volatility. Operating income amounted to Baht 19,168 million, an increase of 5.9% driven by the increase in net interest income of 9.4% mainly from growth in loan portfolio with non

13.58% from the same period in 2018. The decrease in revenue resulted mainly from the decline of revenues from the manufacturing and selling of Special Cutting Tools segment, which include sales from the

 72,000 in 2Q17 re while targetin rice.  Fixed  bro ervice revenue  owth momentu ven  by  both  usiness. Overal &A rose QoQ as  mainly driven  TDA  was  Bt17,1 h a margin of 4 25% YoY and 6 rk expansion

Polymer business unit was risen by 2.67%. And the sales value of Specialty Chemicals business unit was decreased by 32.05%. The 4.79% decrease in total sales revenue was mainly due to the decline in sales

assets as of December 31, 2016. Cash increased by 17.8 million baht while trade and other receivable decreased 3.2 million baht. The receivable was mainly from the decreased of the other receivable

Engineering Polymer business unit was dropped by 0.86%. And the sales value of Specialty Chemicals business unit was increased by 5.02%. The 14.20% decrease in total sales revenue was mainly due to the decline